Rheumatoid Arthritis
Conditions
Interventions
Sequence 1:Weeks1~2:Oral Tibetan medicine.Weeks3~4:Oral Tibetan medicine+Tibetan medicine bath therapy+Hor ma therapy+topical application therapy.Comprehensive Tibetan Medicine Bath Therapy:Oral Tibet
Sponsors
Tibet Autonomous Region Tibetan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for rheumatoid arthritis in Western medicine; (2) Meets the diagnostic criteria for (Changzhong) in Tibetan medicine; (3) Aged between 18 and 75 years old; (4) No use of systemic Western medications for rheumatoid arthritis in the past 3 months.
Exclusion criteria
Exclusion criteria: (1) Patients with other severe autoimmune diseases, such as systemic lupus erythematosus, Sjögren's syndrome, myositis, etc.; (2) Patients with skin lesions (including skin damage, infection, ulcers, etc.), infectious diseases, fever, debility, asthma, edema, coronary heart disease, acute cerebral hemorrhage, hypokalemia, acute cholecystitis, heart rate below 45 beats per minute, or alcohol allergy, who are not suitable for Tibetan herbal bath; (3) Patients with skin diseases or pustules who are not suitable for topical application; (4) Patients with C-reactive protein or erythrocyte sedimentation rate (ESR) more than three times above the upper limit of normal, or both C-reactive protein and ESR more than two times above the upper limit of normal; (5) Patients allergic to the drugs used in this study or patients with allergic constitution; (6) Patients with severe primary diseases of the heart, liver, kidney, brain, endocrine system, or hematopoietic system, malignant tumors, or mental disorders; (7) Pregnant women, breastfeeding women, or women planning pregnancy within three months; (8) Patients who have participated in or are currently participating in other interventional clinical trials within the past three months; (9) Other situations deemed unsuitable for this study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The 28-joint disease activity index, Disease Activity Score in 28 joints (DAS28), is calculated using C-reactive protein (CRP).;Patient's assessment of pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease Activity;The patient's overall assessment of disease activity;The doctor's overall assessment of disease activity.;Joint involvement and severity;Physical Functions and Disabilities; | — |
Countries
China
Contacts
Public ContactTsering Samdrup
Tibet Autonomous Region Tibetan Hospital (Tibet Autonomous Region Research Institute of Tibetan Medicine)
Outcome results
None listed